Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProNex Pharma, officially known as ProNex Pharmaceuticals, is a prominent Egyptian pharmaceutical company specializing in the development, manufacturing, and distribution of generic medications and nutritional supplements. Headquartered in Cairo, the company operates a state-of-the-art manufacturing facility in Badr City that adheres to international Good Manufacturing Practice (GMP) standards. ProNex Pharma's product portfolio covers a wide range of therapeutic areas, with a particular focus on anti-infectives, respiratory health, and gastroenterology. The company serves the healthcare needs of the Middle East and North Africa (MENA) region by providing high-quality, affordable alternatives to brand-name drugs. In addition to its commercial operations, ProNex Pharma offers contract manufacturing services to regional and international partners. Its commitment to quality and accessibility has established it as a key player in the Egyptian private pharmaceutical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProNex Pharma.